Key pointsIn patients admitted to hospital with severe acute bronchitis and/or decompensated comorbidity, the need for antibacterial treatment requires careful clinical judgment - In patients admitted to hospital with acute exacerbations of COPD, respiratory viral pathogens are identified in the majority - In patients with COPD, there is an association between lung function and the pattern of respiratory bacterial pathogens isolated. Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis are usually implicated in patients with mild to moderate disease - In patients admitted to hospital with community acquired pneumonia (CAP), assessment of initial pneumonia severity is important to guide decisions regarding site of care and initial empiric antibacterial treatment - Patients with severe CAP should be treated with combination therapy, usually a broad spectrum β-lactam plus, either a macrolide or a respiratory quinolone antibiotic.
Chapter. 3205 words.
Subjects: Respiratory Medicine and Pulmonology
Full text: subscription required
Users without a subscription are not able to see the full content. Please, subscribe or login to access all content. subscribe or purchase to access all content.